Source: Andrew Pollack, The New York Times

The Food and Drug Administration continues to have concerns that a weight-loss drug it is reviewing for the second time can cause birth defects and heart problems, documents released by the agency on Friday show. The drug, called Qnexa, was rejected by the agency in 2010, largely because of those risks. A committee of outside advisers to the F.D.A. will meet on Wednesday to consider again whether the drug, developed by Vivus, should be approved.

Read Full Article: Side effects of diet pill still concern regulators